Lilly Signs Deals With Dexcom, Glooko, myDiabby, Roche For Diabetes Management Solutions

Lilly announced it signed strategic international agreements with four diabetes companies to advance connected solutions and streamline care for people with diabetes in markets outside of the US.

Partnership

Eli Lilly and Company will partner with Dexcom, Glooko, Inc., myDiabby Healthcare and Roche Diabetes Care, which have developed diabetes management platforms that can be paired with Lilly’s TempoPen and Tempo Smart Button to help people manage their diabetes.

Lilly’s TempoPen is a modified version of its existing prefilled, disposable insulin pen

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Deals

More from Business